Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 19
498
Views
17
CrossRef citations to date
0
Altmetric
Research Articles

Meroterpenoids and alkaloids from Ganoderma australe

, , , &
Pages 3226-3232 | Received 27 Aug 2019, Accepted 06 Nov 2019, Published online: 19 Nov 2019
 

Abstract

Two new mertoterpenoids, australins A (1) and B (2), and a new alkaloid, australine (4), together with five known compounds (3, 58) were isolated from the fruiting bodies of Ganoderma australe. Their structures including absolute configurations were assigned by using spectroscopic methods and electronic circular dichroism (ECD) calculations. Racemic australin A was further purified by chiral HPLC. Biological assessments reveal that compounds (+)-1 and 7 could significantly protect SH-SY5Y cells from glutamate-induced neural excitotoxicity.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by National Science Fund for NSFC-Joint Foundation of Yunnan Province (U1702287), Distinguished Young Scholars (81525026), National Natural Science Foundation of China (31700932), National Key Research and Development Program of China (2017YFA0503900), Shenzhen Science and Technology Innovation Committee for Basic Research (JCYJ20170307170742519).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.